Skip to main content
SpringerLink
Log in

Diagnostic Accuracy of Carcinoembryonic Antigen (CEA) in Detecting Colorectal Cancer Recurrence Depending on Its Preoperative Level

  • Original Article
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Background

Serum carcinoembryonic antigen (CEA) increase in patients with colorectal cancer (CRC) recurrence was observed to vary depending on their initial values. This study aimed to evaluate the diagnostic accuracy of CEA for detecting CRC recurrence in patients with normal and elevated initial CEA levels.

Methods

A total of 261 CRC recurrence patients who underwent curative resection were included and divided into two groups, normal and elevated initial CEA. Analysis was performed comparing patient, tumor, and recurrence characteristics retrospectively.

Results

There were 192 patients with normal and 69 with high initial CEA levels. Patient and tumor characteristics were similar. Eighty-six patients had elevated CEA at the time of recurrence, and the overall sensitivity of CEA for recurrence was 33.0%. In the high initial CEA group, 59.4% exhibited increased CEA level at recurrence, whereas in patients with normal initial CEA levels, only 23.4% showed elevated levels (p < 0.001). Patients with both high CEA preoperatively and at recurrence had more local recurrence, but there was no statistical significance (p = 0.053), and the rate of lung metastasis was higher in patients whose CEA remained normal at recurrence (38.3% vs. 24.4%, p = 0.026). The overall survival of patients with elevated CEA at recurrence was worse than those with normal CEA levels (56.9% vs. 42.4%, p = 0.003).

Conclusion

The diagnostic accuracy of CEA for detecting recurrence depends on initial CEA level. Regardless of the initial CEA level, elevation at recurrence was significantly associated with overall survival in patients with recurrent CRC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Data Availability

The participants of this study did not give written consent for their data to be shared publicly, so due to the sensitive nature of the research supporting data is not available.

References

  1. Tan E, Gouvas N, Nicholls RJ, et al. Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer. Surg Oncol. 2009;18(1):15-24. https://doi.org/10.1016/j.suronc.2008.05.008

    Article  PubMed  Google Scholar 

  2. Newton KF, Newman W, Hill J. Review of biomarkers in colorectal cancer. Colorectal Dis. 2012;14(1):3-17. https://doi.org/10.1111/j.1463-1318.2010.02439.x

    Article  CAS  PubMed  Google Scholar 

  3. Fang MY, Wang SY, Zheng YB, et al. Prognostic and predictive significance of plasma hepatocyte growth factor and carcinoembryonic antigen in non-small lung cancer after surgery. Eur Rev Med Pharmacol Sci. 2014;18(3):398-403.

    PubMed  Google Scholar 

  4. Kang HY, Choe EK, Park KJ, et al. Factors Requiring Adjustment in the Interpretation of Serum Carcinoembryonic Antigen: A Cross-Sectional Study of 18,131 Healthy Nonsmokers. Gastroenterol Res Pract. 2017;2017:9858931. https://doi.org/10.1155/2017/9858931

    Article  PubMed  PubMed Central  Google Scholar 

  5. Lu J, Wang H, Zhang X, et al. HbA1c is Positively Associated with Serum Carcinoembryonic Antigen (CEA) in Patients with Diabetes: A Cross-Sectional Study. Diabetes Ther. 2018;9(1):209-217. https://doi.org/10.1007/s13300-017-0356-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Huang CS, Chen CY, Huang LK, et al. Prognostic value of postoperative serum carcinoembryonic antigen levels in colorectal cancer patients who smoke. PLoS One. 2020;15(6):e0233687. https://doi.org/10.1371/journal.pone.0233687

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Moertel CG, O'Fallon JR, Go VL, et al. The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer. Cancer. 1986;58(3):603-610. https://doi.org/10.1002/1097-0142(19860801)58:3<603::aid-cncr2820580302>3.0.co;2-k

    Article  CAS  PubMed  Google Scholar 

  8. Sharma S. Tumor markers in clinical practice: General principles and guidelines. Indian J Med Paediatr Oncol. 2009;30(1):1-8. https://doi.org/10.4103/0971-5851.56328

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Thirunavukarasu P, Talati C, Munjal S, et al. Effect of Incorporation of Pretreatment Serum Carcinoembryonic Antigen Levels Into AJCC Staging for Colon Cancer on 5-Year Survival. JAMA Surg. 2015;150(8):747-755. https://doi.org/10.1001/jamasurg.2015.0871

    Article  PubMed  Google Scholar 

  10. Becerra AZ, Probst CP, Tejani MA, et al. Evaluating the Prognostic Role of Elevated Preoperative Carcinoembryonic Antigen Levels in Colon Cancer Patients: Results from the National Cancer Database. Ann Surg Oncol. 2016;23(5):1554-1561. https://doi.org/10.1245/s10434-015-5014-1

    Article  PubMed  Google Scholar 

  11. Das V, Kalita J, Pal M. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges. Biomed Pharmacother. 2017;87:8-19. https://doi.org/10.1016/j.biopha.2016.12.064

    Article  CAS  PubMed  Google Scholar 

  12. Yoshikawa M, Morine Y, Ikemoto T, et al. Elevated Preoperative Serum CEA Level Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma Through the Epithelial-Mesenchymal Transition. Anticancer Res. 2017;37(3):1169-1175. https://doi.org/10.21873/anticanres.11430

    Article  CAS  PubMed  Google Scholar 

  13. Konishi T, Shimada Y, Hsu M, et al. Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome. JAMA Oncol. 2018;4(3):309-315. https://doi.org/10.1001/jamaoncol.2017.4420

    Article  PubMed  Google Scholar 

  14. Huang SH, Tsai WS, You JF, et al. Preoperative Carcinoembryonic Antigen as a Poor Prognostic Factor in Stage I-III Colorectal Cancer After Curative-Intent Resection: A Propensity Score Matching Analysis. Ann Surg Oncol. 2019;26(6):1685-1694. https://doi.org/10.1245/s10434-019-07184-3

    Article  PubMed  Google Scholar 

  15. Ramphal W, Boeding JRE, van Iwaarden M, et al. Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer. Int J Biol Markers. 2019;34(1):60-68. https://doi.org/10.1177/1724600818820679

    Article  CAS  PubMed  Google Scholar 

  16. Su BB, Shi H, Wan J. Role of serum carcinoembryonic antigen in the detection of colorectal cancer before and after surgical resection. World J Gastroenterol. 2012;18(17):2121-2126. https://doi.org/10.3748/wjg.v18.i17.2121

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Locker GY, Hamilton S, Harris J, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol. 2006;24(33):5313-5327. https://doi.org/10.1200/JCO.2006.08.2644

    Article  CAS  PubMed  Google Scholar 

  18. Duffy MJ, Lamerz R, Haglund C, et al. Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update. Int J Cancer. 2014;134(11):2513-2522. https://doi.org/10.1002/ijc.28384

    Article  CAS  PubMed  Google Scholar 

  19. National Institute for Health and Care Excellence Colorectal Cancer: Diagnosis and Management NICE Clinical Guideline 2020;151. https://www.niceorguk/guidance/ng151. Accessed 15 Dec 2021

  20. Argiles G, Tabernero J, Labianca R, et al. Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(10):1291-1305. https://doi.org/10.1016/j.annonc.2020.06.022

    Article  CAS  PubMed  Google Scholar 

  21. Benson AB, Venook AP, Al-Hawary MM, et al. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021;19(3):329-359. https://doi.org/10.6004/jnccn.2021.0012

    Article  PubMed  Google Scholar 

  22. Moertel CG, Fleming TR, Macdonald JS, et al. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA. 1993;270(8):943-947.

    Article  CAS  PubMed  Google Scholar 

  23. Chen CC, Yang SH, Lin JK, et al. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer? J Surg Res. 2005;124(2):169-174. https://doi.org/10.1016/j.jss.2004.08.013

    Article  CAS  PubMed  Google Scholar 

  24. Park IJ, Choi GS, Lim KH, et al. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level. Ann Surg Oncol. 2009;16(11):3087-3093. https://doi.org/10.1245/s10434-009-0625-z

    Article  PubMed  Google Scholar 

  25. Khan MA, Maken RN, Nisar H, et al. THE Role of Preoperative carcinoembryonic antigen in recurrence of resectable colorectal carcinoma. Acta Clin Croat. 2020;59(2):216-222. https://doi.org/10.20471/acc.2020.59.02.03

    Article  PubMed  PubMed Central  Google Scholar 

  26. Glynne-Jones R, Wyrwicz L, Tiret E, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(suppl_4):iv22-iv40. https://doi.org/10.1093/annonc/mdx224

    Article  CAS  PubMed  Google Scholar 

  27. Baek SJ, Kim SH, Kwak JM, et al. Selective use of preoperative chemoradiotherapy for T3 rectal cancer can be justified: analysis of local recurrence. World J Surg. 2013;37(1):220-226. https://doi.org/10.1007/s00268-012-1792-9

    Article  PubMed  Google Scholar 

  28. McCall JL, Black RB, Rich CA, et al. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum. 1994;37(9):875-881. https://doi.org/10.1007/BF02052591

    Article  CAS  PubMed  Google Scholar 

  29. Shinkins B, Primrose JN, Pugh SA, et al. Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial. Br J Surg. 2018;105(6):658-662. https://doi.org/10.1002/bjs.10819

    Article  CAS  PubMed  Google Scholar 

  30. Michl M, Koch J, Laubender RP, et al. Tumor markers CEA and CA 19-9 correlate with radiological imaging in metastatic colorectal cancer patients receiving first-line chemotherapy. Tumour Biol. 2014;35(10):10121-10127. https://doi.org/10.1007/s13277-014-2280-7

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Colon and Rectal Surgery, Department of Surgery, Korea University College of Medicine, Seoul, Korea

    Tae-Hoon Lee, Ji-Seon Kim, Se-Jin Baek, Jung-Myun Kwak & Jin Kim

Authors
  1. Tae-Hoon Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ji-Seon Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Se-Jin Baek
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jung-Myun Kwak
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jin Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SJB mainly provided the main conceptualization, and THL wrote this manuscript; and JSK, JMK, and JK reviewed the paper.

Corresponding author

Correspondence to Se-Jin Baek.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, TH., Kim, JS., Baek, SJ. et al. Diagnostic Accuracy of Carcinoembryonic Antigen (CEA) in Detecting Colorectal Cancer Recurrence Depending on Its Preoperative Level. J Gastrointest Surg 27, 1694–1701 (2023). https://doi.org/10.1007/s11605-023-05761-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-023-05761-2

Keywords

Search

Navigation